Native Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -3.11%
(FY 2022)
- Ebitda -12.55%
(FY 2022)
- Net Worth -65.24%
(FY 2022)
- Total Assets -45.80%
(FY 2022)
About Native Biologicals
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivasubraman Mukunthakumar and Krishnasamy Dhanakumar serve as directors at the Company.
- CIN/LLPIN
U74999TZ2018PTC030449
- Company No.
030449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2018
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Native Biologicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasubraman Mukunthakumar  | Additional Director | 28-Sep-2020 | Current |
| Krishnasamy Dhanakumar | Director | 09-May-2018 | Current |
Financial Performance of Native Biologicals.
Native Biologicals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 65.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Native Biologicals?
Unlock access to Native Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Foundation One Infrastructures Private LimitedActive 17 years 18 daysKrishnasamy Dhanakumar is a mutual person
Thera Nutraceuticals Private LimitedActive 6 years 1 monthSivasubraman Mukunthakumar and Krishnasamy Dhanakumar are mutual person
- Overseas Beverages Private LimitedActive 23 years 2 months
Sivasubraman Mukunthakumar is a mutual person
- The White Horse Distilleries Private LimitedActive 23 years 1 month
Krishnasamy Dhanakumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Native Biologicals?
Unlock and access historical data on people associated with Native Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Native Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Native Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
